RecruitingPhase 1Phase 2NCT07096934

Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care

A Prospective, Randomized, Controlled Trial to Evaluate the Safety and Efficacy of CYWC628 (Human Dermal Fibroblast Spheroids) for the Treatment of Refractory Diabetic Foot Ulcers Compared With Standard of Care


Sponsor

FibroBiologics

Enrollment

120 participants

Start Date

Jun 1, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, multicentre, randomized clinical trial evaluating the safety, tolerability, and efficacy of up to 12 weeks treatment with SoC + low- or high-dose CYWC628 in treating DFU, compared to SoC only.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called SoC + High dose CYWC628, a biological treatment called SoC + Low dose CYWC628, and others for people with diabetic foot ulcer (dfu). The study is currently recruiting participants at 9 locations. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERStandard of Care (SOC)

The participant's DFU will be sharply debrided (as needed), dressed with SoC and offloaded.

BIOLOGICALSoC + Low dose CYWC628

The participant's DFU will be sharply debrided (as needed), dressed with SoC and offloaded. Low dose CYWC628 applied once weekly to diabetic foot ulcer (DFU) for up to 12 weeks

BIOLOGICALSoC + High dose CYWC628

The participant's DFU will be sharply debrided (as needed), dressed with SoC and offloaded. High dose CYWC628 applied once weekly to diabetic foot ulcer (DFU) for up to 12 weeks


Locations(9)

Coffs Harbour Health Campus

Coffs Harbour, New South Wales, Australia

Hunter Medical Research Institute

New Lambton Heights, New South Wales, Australia

Royal North Shore Hospital

Saint Leonards, New South Wales, Australia

Canopy Clinical Wollongong

Wollongong, New South Wales, Australia

Mater Misericordiae Ltd

South Brisbane, Queensland, Australia

Mackay Hospital and Health Service

West Mackay, Queensland, Australia

Monash House Research Centre

Clayton, Victoria, Australia

Caulfield - Alfred

Melbourne, Victoria, Australia

Sir Charles Gardeners Hospital

Nedlands, Western Australia, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07096934


Related Trials